Are you currently experiencing brain fog from Long COVID?
If you are currently experiencing brain fog and symptoms of Long COVID, you may be eligible to join our study looking to better understand neurological and psychological symptoms in people who are recovering from COVID-19.
The purpose of this research study is to identify changes on MRI in patients who have cognitive changes and have had COVID-19.
Study procedures include (compensation provided): blood draws, MRI with contrast, complete a set of memory tasks and health surveys, and a lumbar puncture (optional). Co-enrollment in our Biobank study, HIC#1502015318 (with separate compensation provided).
To learn more or see if you are eligible to participate, please contact us at (475) 434-4324 or email: NeuroID@yale.edu.
Sponsored by National Institute of Mental Health (NIMH); National Institute of Neurological Disorders and Stroke (NINDS); Yale University School of Medicine; HIC# 2000031278
Planning to update your COVID vaccine?
Yale researchers are studying the immune response to COVID vaccinations among healthy and immune suppressed individuals. If you are planning to update your vaccine, you may qualify for a research study.
Qualifying participants should be:
EITHER:
- Healthy (no history of immune problems and not taking any immune suppressing medicine)
- Taking a B-cell depleting medicine (e.g. rituximab, ocrelizumab, ofatumumab) to treat an autoimmune disease
- Taking glatiramer or interferon-type medication to treat an autoimmune disease
Participants in this research project will have a fine needle aspiration and/or biopsy of lymph nodes in their armpit before and at several timepoints after vaccination. Ultrasounds will be performed before these procedures to visualize the lymph nodes. Blood will also be collected. There would be 4-6 study visits over about 10 weeks.
Compensation of up to $750 is available.
If you are interested, please complete the pre-screening survey at https://redcap.link/9md3047j or email MSResearch@yale.edu.
Sponsored by Hoffmann (F) - La Roche, Ltd; National Institute of Allergy and Infectious Diseases (NIAID); Robert Leet and Clara Guthrie Patterson Trust; Yale University School of Medicine.; HIC#2000032631
COVID Mind Study
Do you have difficulty with concentration, headaches, sadness or anxiety, or other ongoing neurological and psychological symptoms after having COVID-19?
You may be eligible for a research study visit to aid our understanding of COVID-19’s effects on the brain. You may qualify if you had previously confirmed COVID-19 diagnosis, have new or lingering symptoms after acute COVID-19 infection, are 18 years old or older.
Earn up to $150 for participating in a 5-hour visit including a blood draw, lumbar puncture (spinal tap), surveys, and neuropsychological testing.
If you are interested, please contact us at 475-434-4324 or email neuroid@yale.edu
Sponsored by Merck Sharp & Dohme; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Mental Health (NIMH); Yale University School of Medicine; HIC# 1502015318
Do you have lupus, rheumatoid arthritis or pemphigus?
COVID-19 Vaccine Study in Autoimmune Patients
People with autoimmune disease are at risk for COVID-19 because of the medication they take. Help us improve protection by joining Yale clinical trial ACV01 now. Enrolling patients with lupus, rheumatoid arthritis and pemphigus. Principal Investigator is Dr. Fotios Koumpouras, Director, Yale Lupus Program.
To learn more or see if you are eligible to participate, call 203-785-6631 or email lupus@yale.edu.
Sponsored by Emory University; HIC# 2000031152